Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
20 déc. 2024 16h53 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services...
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
03 déc. 2024 17h18 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
15 nov. 2024 18h15 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company received...
Procaps Issues Shareholder Letter Update
10 oct. 2024 17h26 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Issues Shareholder Letter Update
18 sept. 2024 08h10 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Issues Shareholder Letter
03 sept. 2024 09h10 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Group Reports First Quarter 2023 Results
05 juin 2023 19h45 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, June 05, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated international healthcare and pharmaceutical services company,...
Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing
01 mai 2023 08h17 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance
13 févr. 2023 16h36 HE
|
Procaps Group, S.A.
Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board of Directors to Focus on Profitable Growth Announces $5M+ Share Repurchase Program ...
Procaps Announces Key Changes to the Board of Directors
19 janv. 2023 16h32 HE
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...